Our study shows that resistin is positively correlated to other cytokines in the whole patient group, reflecting the inflammatory state generated by T1D; however, when we divided the group, only the patients with MS consistently showed this positive correlation, while the patients without MS showed a small and nonsignificant correlation. The gene discussed is RETN; the disease is myeloid sarcoma.